Subchapter 23 - MEDICATION AND TESTING PROCEDURES
- Section 13:71-23.1 - Intent of medication rules; general provisions
- Section 13:71-23.2 - Testing
- Section 13:71-23.3 - Pre-race blood testing program
- Section 13:71-23.3A - Post-race blood gas testing program
- Section 13:71-23.3B - Post-race blood gas testing program; pre-race guarded quarantine
- Section 13:71-23.3C - Post-race blood gas testing program; punishment for failure to cooperate
- Section 13:71-23.4 - Post-race testing program; split urine or split blood samples
- Section 13:71-23.5 - Procedure following positive chemical analysis
- Section 13:71-23.6 - Trainers
- Section 13:71-23.7 - Penalties
- Section 13:71-23.8 - Administering medication to respiratory bleeders; standards for the administration of non-steroidal anti-inflammatory drugs (NSAID) and anti-ulcer medications; environmental contaminants
- Section 13:71-23.9 - Possession of drugs or drug instruments
- Section 13:71-23.10 - Illegal devices
- Section 13:71-23.11 - Narcotics conviction; denial of license
- Section 13:71-23.12 - Cooperation with other agencies; violations of law
- Section 13:71-23.13 - State Police; responsibilities
- Section 13:71-23.14 - Anti-recombinant human EPO antibody testing program
- Section 13:71-23.15 - Out-of-competition testing (on non-race days and on race days pre-race) of racehorses for Erythropoietin (Epogen, EPO), DarbEPO, or other blood doping agents; penalties, procedures, and testing costs for positive test results for Erythropoietin (Epogen, EPO), DarbEPO, or other blood doping agents, as a result of out-of-competition testing; penalties, procedures, and testing costs for positive test results for Erythropoietin (Epogen, EPO), DarbEPO, or other blood doping agents, as a result of post-race blood sample testing (on race days) conducted pursuant to other provisions of this chapter
- Section 13:71-23.16 - Anabolic steroids
- Section 13:71-23.17 - Shock wave therapy
- Section 13:71-23.17A - Penalties for violating N.J.A.C. 13:71-23.17